Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Perou

Showing results (381-390 of 476) with videos related to

Pageof 48
Sort By:
Communications Medicine|January 8, 2025
Gene signatures derived from transcriptomic-causal networks stratify colorectal cancer patients for effective targeted therapyAkram Yazdani, Heinz-Josef Lenz, Gianluigi Pillonetto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2012
TBCRC 001: randomized phase II study of cetuximab in combination with carboplatin in stage IV triple-negative breast cancerLisa A Carey, Hope S Rugo, P Kelly Marcom, et al.
NPJ Precision Oncology|April 17, 2018
Discrete microfluidics for the isolation of circulating tumor cell subpopulations targeting fibroblast activation protein alpha and epithelial cell adhesion moleculeMałgorzata A Witek, Rachel D Aufforth, Hong Wang, et al.
Archives of Pathology & Laboratory Medicine|January 14, 2020
Estrogen and Progesterone Receptor Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Guideline UpdateKimberly H Allison, M Elizabeth H Hammond, Mitchell Dowsett, et al.
Nature|January 10, 2024
MRE11 liberates cGAS from nucleosome sequestration during tumorigenesisMin-Guk Cho, Rashmi J Kumar, Chien-Chu Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2018
Integrated Analysis of RNA and DNA from the Phase III Trial CALGB 40601 Identifies Predictors of Response to Trastuzumab-Based Neoadjuvant Chemotherapy in HER2-Positive Breast CancerMaki Tanioka, Cheng Fan, Joel S Parker, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 30, 2015
Performance of Three-Biomarker Immunohistochemistry for Intrinsic Breast Cancer Subtyping in the AMBER ConsortiumEmma H Allott, Stephanie M Cohen, Joseph Geradts, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 20, 2024
Prognostic value of residual disease (RD) biology and gene expression changes during the neoadjuvant treatment in patients with HER2-positive early breast cancer (EBC)A Fernandez-Martinez, M Tanioka, S G Ahn, et al.
Research Square|January 3, 2024
Gene signatures derived from transcriptomic-causal networks stratified colorectal cancer patients for effective targeted therapyAkram Yazdani, Heinz-Josef Lenz, Gianluigi Pillonetto, et al.
The Journal of Clinical Investigation|February 27, 2018
Integrated RNA and DNA sequencing reveals early drivers of metastatic breast cancerMarni B Siegel, Xiaping He, Katherine A Hoadley, et al.
Pageof 48

Showing results (381-390 of 476) with videos related to

Sort By:
Pageof 48
Communications Medicine|January 8, 2025
Gene signatures derived from transcriptomic-causal networks stratify colorectal cancer patients for effective targeted therapyAkram Yazdani, Heinz-Josef Lenz, Gianluigi Pillonetto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2012
TBCRC 001: randomized phase II study of cetuximab in combination with carboplatin in stage IV triple-negative breast cancerLisa A Carey, Hope S Rugo, P Kelly Marcom, et al.
NPJ Precision Oncology|April 17, 2018
Discrete microfluidics for the isolation of circulating tumor cell subpopulations targeting fibroblast activation protein alpha and epithelial cell adhesion moleculeMałgorzata A Witek, Rachel D Aufforth, Hong Wang, et al.
Archives of Pathology & Laboratory Medicine|January 14, 2020
Estrogen and Progesterone Receptor Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Guideline UpdateKimberly H Allison, M Elizabeth H Hammond, Mitchell Dowsett, et al.
Nature|January 10, 2024
MRE11 liberates cGAS from nucleosome sequestration during tumorigenesisMin-Guk Cho, Rashmi J Kumar, Chien-Chu Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2018
Integrated Analysis of RNA and DNA from the Phase III Trial CALGB 40601 Identifies Predictors of Response to Trastuzumab-Based Neoadjuvant Chemotherapy in HER2-Positive Breast CancerMaki Tanioka, Cheng Fan, Joel S Parker, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 30, 2015
Performance of Three-Biomarker Immunohistochemistry for Intrinsic Breast Cancer Subtyping in the AMBER ConsortiumEmma H Allott, Stephanie M Cohen, Joseph Geradts, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 20, 2024
Prognostic value of residual disease (RD) biology and gene expression changes during the neoadjuvant treatment in patients with HER2-positive early breast cancer (EBC)A Fernandez-Martinez, M Tanioka, S G Ahn, et al.
Research Square|January 3, 2024
Gene signatures derived from transcriptomic-causal networks stratified colorectal cancer patients for effective targeted therapyAkram Yazdani, Heinz-Josef Lenz, Gianluigi Pillonetto, et al.
The Journal of Clinical Investigation|February 27, 2018
Integrated RNA and DNA sequencing reveals early drivers of metastatic breast cancerMarni B Siegel, Xiaping He, Katherine A Hoadley, et al.
Pageof 48